1-4 of 4
Carol Krasnov
Close
Sort by
Journal Articles

Long Term Effects on GVHD and Survival Following the Use of G-CSF Stimulated Bone Marrow Versus G-CSF Mobilized Peripheral Blood Stem Cells in HLA Matched Sibling Transplant.

Anne W. Beaven, MD, Thomas C. Shea, MD, Don A. Gabriel, MD, PhD, Terrance Comeau, MD, Robert Irons, PA, Dominic T. Moore, MS, MPH, Li Lin, MS, Andrew Sharf, RN, Carol Krasnov, Mark E. Brecher, MD, Jonathan Serody, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5385.
https://doi.org/10.1182/blood.V106.11.5385.5385
Published: 2005
Journal Articles

Clinical and Pharmacokinetic Results of a Four-Day Continuous Infusion of Full-Dose Busulfan in Patients (pts) Undergoing Matched Related (MRD) or Unrelated (MUD) Stem Cell Transplant (SCT).

Thomas C. Shea, MD, Christine Walko, PharmD, Don Gabriel, MD, PhD, Jon Serody, MD, PhD, Terrance Comeau, MD, Robert Irons, PA, Andrew Gilman, MD, Carol Krasnov, Andrew Sharf, RN, Celeste Lindley, PharmD
Journal: Blood
Blood (2005) 106 (11): 1752.
https://doi.org/10.1182/blood.V106.11.1752.1752
Published: 2005
Journal Articles

Successful Re-Engraftment after Second Allogeneic Transplantation for Graft Failure in Patients with Refractory Hematologic Malignancies.

Don A. Gabriel, MD, PhD, James Coghill, MD, Thomas C. Shea, MD, Terrance Comeau, MD, Robert Irons, P-AC, Carol Krasnov
Journal: Blood
Blood (2004) 104 (11): 5120.
https://doi.org/10.1182/blood.V104.11.5120.5120
Published: 2004
Journal Articles

High Relapse Rate Following Alemtuzamab Use in Allogeneic Transplants for Myeloid Hematologic Malignancies.

Thomas C. Shea, MD, Jonathan Serody, MD, PhD, Don Gabriel, MD, PhD, Terrance Comeau, MD, Donald Harvey, PharmD, Robert Irons, PA, David Morris, MD, Andrew Sharf, RN, Carol Krasnov, Cherie Dunphy, MD, Nicholas Banderenko, MD, Mark Brecher, MD
Journal: Blood
Blood (2004) 104 (11): 1826.
https://doi.org/10.1182/blood.V104.11.1826.1826
Published: 2004